GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 154 filers reported holding GERON CORP in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43,954 | -51.7% | 20,733 | -26.9% | 0.00% | – |
Q2 2023 | $91,068 | +99.3% | 28,370 | +34.8% | 0.00% | – |
Q1 2023 | $45,683 | +552.6% | 21,052 | +345.2% | 0.00% | – |
Q2 2022 | $7,000 | +75.0% | 4,729 | +81.9% | 0.00% | – |
Q1 2022 | $4,000 | +33.3% | 2,600 | -0.9% | 0.00% | – |
Q4 2021 | $3,000 | -25.0% | 2,623 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | -50.0% | 2,623 | -53.6% | 0.00% | – |
Q2 2021 | $8,000 | -70.4% | 5,653 | -66.8% | 0.00% | – |
Q1 2021 | $27,000 | +800.0% | 17,023 | +741.5% | 0.00% | – |
Q4 2020 | $3,000 | -25.0% | 2,023 | +1.2% | 0.00% | – |
Q3 2020 | $4,000 | 0.0% | 2,000 | -1.1% | 0.00% | – |
Q2 2020 | $4,000 | – | 2,023 | +8695.7% | 0.00% | – |
Q3 2019 | $0 | – | 23 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 23 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 23 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 23 | 0.0% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 23 | -99.6% | 0.00% | -100.0% |
Q2 2018 | $21,000 | +5.0% | 6,000 | +20.0% | 0.00% | 0.0% |
Q1 2018 | $20,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |